Everdrone, a “global leader in autonomous drone technology,”announced this week, the company has been approved for its first patent by the European Patent Office (EPO), reports a press release.
The release says, “The recently approved patent relates to a method of comparing camera data in order to automatically validate that the onboard sensors are working correctly, thereby making drone operations safer.”
Everdrone’s latest patented technology focuses on “combining vision technology with unmanned aerial vehicles (UAV) to allow drones to fly safely and accurately in low altitude airspace where obstacles such as buildings and vegetation are often present.”
Everdrone offers a service where drones equipped with Automated External Defibrillators (AEDs) and other medical supplies are flown to the scene of emergency situations, in conjunction with local emergency services and authorities. The company works with Sweden’s national emergency call centre, SOS Alarm, and the Centre for Resuscitation Science at Karolinska Institutet (KI) for research and development.
More recently, Everdrone expanded its reach into Denmark in partnership with Copenhagen Emergency Medical Services. Copenhagen EMS acts as a research partner and is responsible for emergency dispatch services to determine which calls need priority drone assistance, while Everdrone coordinates the delivery of AEDs via drone to the scene of cardiac arrests.
CEO of Everdrone, Mats Sällström, commented, “This patent demonstrates our commitment to safety and is one of several patents we’re working towards to continue driving our primary mission of saving lives.”
To date, the company has performed more than 13,000 autonomous flights in laboratory and outdoor settings, as well as more than 1.8 million simulated flights
Visual presentation
https://www.everdrone.com/service
For more information
